Literature DB >> 20381538

Effect size of reference memory deficits in the Morris water maze in Tg2576 mice.

Miranda N Reed1, Peng Liu, Linda A Kotilinek, Karen H Ashe.   

Abstract

The most widely used mouse model of Alzheimer's disease is the Tg2576 (APP(SWE)) model. While general agreement about their neuropathology prevails, disparate results concerning cognitive changes have been reported. To resolve this controversy, we combined Morris water maze data collected over >10 years to determine the extent of memory impairment. APP(SWE) mice exhibited an age-dependent decline in memory, but the effect size was small when compared to non-transgenic littermates. Larger effect sizes were achieved when comparing APP(SWE) and Tg5469 (APP(WT)) mice. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381538      PMCID: PMC2903868          DOI: 10.1016/j.bbr.2010.03.037

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  30 in total

1.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

2.  The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Marcus A Westerman; Deirdre Cooper-Blacketer; Ami Mariash; Linda Kotilinek; Takeshi Kawarabayashi; Linda H Younkin; George A Carlson; Steven G Younkin; Karen H Ashe
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

3.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions.

Authors:  Fiona M Laird; Huaibin Cai; Alena V Savonenko; Mohamed H Farah; Kaiwen He; Tatyana Melnikova; Hongjin Wen; Hsueh-Cheng Chiang; Guilian Xu; Vassilis E Koliatsos; David R Borchelt; Donald L Price; Hey-Kyoung Lee; Philip C Wong
Journal:  J Neurosci       Date:  2005-12-14       Impact factor: 6.167

5.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

Authors:  A Y Hsia; E Masliah; L McConlogue; G Q Yu; G Tatsuno; K Hu; D Kholodenko; R C Malenka; R A Nicoll; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months.

Authors:  David L King; Gary W Arendash
Journal:  Physiol Behav       Date:  2002-04-15

7.  Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.

Authors:  Jun Wang; Lap Ho; Wei Zhao; Kenjiro Ono; Clark Rosensweig; Linghong Chen; Nelson Humala; David B Teplow; Giulio M Pasinetti
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

8.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

9.  Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

Authors:  T Kawarabayashi; L H Younkin; T C Saido; M Shoji; K H Ashe; S G Younkin
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

10.  What is the Most Sensitive Measure of Water Maze Probe Test Performance?

Authors:  Hamid R Maei; Kirill Zaslavsky; Cátia M Teixeira; Paul W Frankland
Journal:  Front Integr Neurosci       Date:  2009-03-09
View more
  8 in total

1.  A novel operant testing regimen for multi-construct cognitive characterization of a murine model of Alzheimer's amyloid-related behavioral impairment.

Authors:  Alice L Blackshear; Wenjin Xu; Maria Anderson; Feng Xu; Mary Lou Previti; William E Van Nostrand; John K Robinson
Journal:  Neurobiol Learn Mem       Date:  2011-07-08       Impact factor: 2.877

2.  Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease.

Authors:  M Cuadrado-Tejedor; I Hervias; A Ricobaraza; E Puerta; J M Pérez-Roldán; C García-Barroso; R Franco; N Aguirre; A García-Osta
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

3.  Morris Water Maze Test: Optimization for Mouse Strain and Testing Environment.

Authors:  Daniel S Weitzner; Elizabeth B Engler-Chiurazzi; Linda A Kotilinek; Karen Hsiao Ashe; Miranda Nicole Reed
Journal:  J Vis Exp       Date:  2015-06-22       Impact factor: 1.355

4.  Sex-dependent behavioral functions of the Purkinje cell-specific Gαi/o binding protein, Pcp2(L7).

Authors:  James C Walton; Karl Schilling; Randy J Nelson; John Oberdick
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

5.  Effect size of memory deficits in mice with adult-onset P301L tau expression.

Authors:  Holly C Hunsberger; Carolyn C Rudy; Daniel S Weitzner; Chong Zhang; David E Tosto; Kevin Knowlan; Ying Xu; Miranda N Reed
Journal:  Behav Brain Res       Date:  2014-07-06       Impact factor: 3.332

Review 6.  Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?

Authors:  Colm Cunningham; Donal Thomas Skelly
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-20       Impact factor: 4.147

7.  VPS35 haploinsufficiency increases Alzheimer's disease neuropathology.

Authors:  Lei Wen; Fu-Lei Tang; Yan Hong; Shi-Wen Luo; Chun-Lei Wang; Wanxia He; Chengyong Shen; Ji-Ung Jung; Fei Xiong; Dae-hoon Lee; Quan-Guang Zhang; Darrell Brann; Tae-Wan Kim; Riqiang Yan; Lin Mei; Wen-Cheng Xiong
Journal:  J Cell Biol       Date:  2011-11-21       Impact factor: 10.539

Review 8.  From a mouse: systematic analysis reveals limitations of experiments testing interventions in Alzheimer's disease mouse models.

Authors:  K J Egan; H M Vesterinen; V Beglopoulos; E S Sena; M R Macleod
Journal:  Evid Based Preclin Med       Date:  2016-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.